NCT00034671View on ClinicalTrials.gov

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

November 30, 2001

Study Completion Date

March 31, 2002

Conditions
Mycoses
Interventions
DRUG

Posaconazole oral suspension

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034671 - PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) | Biotech Hunter | Biotech Hunter